Activated ERKs phosphorylate ERF

Stable Identifier
R-HSA-3209160
Type
Reaction [transition]
Species
Homo sapiens
Compartment
Locations in the PathwayBrowser
General
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout

Activated ERKs (ERK1 i.e. MAPK3 and ERK2 i.e. MAPK1) phosphorylate ERF on threonine residue T526 and possibly other sites. The threonine T526 seems to be the dominant phosphorylation site and its functional relevance has been established (Sgouras et al. 1995, Le Gallic et al. 2004).

Literature References
PubMed ID Title Journal Year
7588608 ERF: an ETS domain protein with strong transcriptional repressor activity, can suppress ets-associated tumorigenesis and is regulated by phosphorylation during cell cycle and mitogenic stimulation

Sgouras, DN, Athanasiou, MA, Beal, GJ, Fisher, RJ, Blair, DG, Mavrothalassitis, GJ

EMBO J. 1995
14729966 ERF nuclear shuttling, a continuous monitor of Erk activity that links it to cell cycle progression

Le Gallic, L, Virgilio, L, Cohen, P, Biteau, B, Mavrothalassitis, G

Mol. Cell. Biol. 2004
Participants
Participant Of
Catalyst Activity
Catalyst Activity
Title
protein serine/threonine kinase activity of p-T,Y MAPK dimers [nucleoplasm]
Physical Entity
Activity
Inferred From
Authored
Reviewed
Created